Sonoma Pharmaceuticals, Inc. — All Filings
947 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
25-NSE
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
REGDEX
REGDEX/A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | FORM 10-Q FOR DEC 2025 | 0001683168-26-000889 | Feb 10, 2026 | Dec 31, 2025 |
| 3 | — | 0001683168-26-000879 | Feb 9, 2026 | Jan 28, 2026 |
| 8-K | CURRENT REPORT | 0001683168-26-000589 | Jan 28, 2026 | — |
| 8-K | FORM 8-K | 0001683168-26-000205 | Jan 12, 2026 | — |
| 4 | — | 0001683168-26-000045 | Jan 2, 2026 | — |
| 4 | — | 0001683168-26-000042 | Jan 2, 2026 | — |
| 4 | — | 0001683168-26-000036 | Jan 2, 2026 | — |
| 4 | — | 0001683168-26-000032 | Jan 2, 2026 | — |
| 4 | — | 0001683168-26-000031 | Jan 2, 2026 | — |
| 4 | — | 0001683168-26-000030 | Jan 2, 2026 | — |
| 8-K | CURRENT REPORT | 0001683168-26-000027 | Jan 2, 2026 | — |
| 10-Q | FORM 10-Q FOR SEP 2025 | 0001683168-25-007938 | Nov 4, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001683168-25-007750 | Oct 23, 2025 | Oct 18, 2025 |
| 8-K | CURRENT REPORT | 0001683168-25-007478 | Oct 9, 2025 | Oct 3, 2025 |
| 8-K | CURRENT REPORT | 0001683168-25-007307 | Sep 29, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-007265 | Sep 26, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-25-007264 | Sep 26, 2025 | — |
| 8-K | FORM 8-K | 0001683168-25-006580 | Aug 29, 2025 | Aug 27, 2025 |
| 10-Q | FORM 10-Q FOR JUNE 2025 | 0001683168-25-005753 | Aug 7, 2025 | Jun 30, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-25-005049 | Jul 11, 2025 | Aug 27, 2025 |
| 4 | — | 0001683168-25-004664 | Jun 20, 2025 | Jun 19, 2025 |
| 4 | — | 0001683168-25-004663 | Jun 20, 2025 | Jun 19, 2025 |
| 4 | — | 0001683168-25-004662 | Jun 20, 2025 | Jun 19, 2025 |
| 4 | — | 0001683168-25-004661 | Jun 20, 2025 | Jun 19, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001683168-25-004549 | Jun 17, 2025 | — |
| 10-K | FORM 10-K FOR MARCH 2025 | 0001683168-25-004546 | Jun 17, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001683168-25-002874 | Apr 28, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-002294 | Apr 7, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-001857 | Mar 25, 2025 | Mar 21, 2025 |
| 10-Q | FORM 10-Q FOR DEC 2024 | 0001683168-25-000736 | Feb 5, 2025 | Dec 31, 2024 |
| 8-K | CURRENT REPORT | 0001683168-25-000611 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | — | 0001683168-25-000084 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001683168-25-000083 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001683168-25-000082 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001683168-25-000081 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001683168-25-000080 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001683168-25-000079 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001683168-25-000078 | Jan 3, 2025 | Jan 2, 2025 |
| 8-K | CURRENT REPORT | 0001683168-25-000076 | Jan 3, 2025 | Jan 2, 2025 |
| 144 | — | 0001971857-25-000039 | Jan 3, 2025 | — |
| 144/A | — | 0001971857-25-000038 | Jan 3, 2025 | — |
| 144/A | — | 0001971857-25-000037 | Jan 3, 2025 | — |
| 144 | — | 0001971857-25-000005 | Jan 2, 2025 | — |
| 144 | — | 0001971857-25-000001 | Jan 2, 2025 | — |
| 144 | — | 0002034802-24-000002 | Dec 26, 2024 | — |
| S-8 | S-8 | 0001683168-24-008892 | Dec 20, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-008332 | Nov 21, 2024 | — |
| 10-Q | FORM 10-Q FOR SEPTEMBER 2024 | 0001683168-24-007708 | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001683168-24-007283 | Oct 22, 2024 | Oct 17, 2024 |
| 8-K | FORM 8-K | 0001683168-24-006556 | Sep 20, 2024 | — |